TERT and skin cancer: Of note, this site is more recurrently mutated than the individual TERT C228T/C250T sites and nearly as frequent as chr7:140453136 mutations (hg19) pertaining to BRAF V600E, thus representing the second most common mutation in melanoma and likely other skin cancers.